+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immunodiagnostics Global Market Opportunities and Strategies to 2033

  • PDF Icon

    Report

  • 296 Pages
  • May 2024
  • Region: Global
  • The Business Research Company
  • ID: 5971175
This report describes and explains the immunodiagnostics market and covers 2018-2023, termed the historic period, and 2023-2028, 2033F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.

The global immunodiagnostics market reached a value of nearly $21.3 billion in 2023, having grown at a compound annual growth rate (CAGR) of 7.8% since 2018. The market is expected to grow from $21.3 billion in 2023 to $30.6 billion in 2028 at a rate of 7.5%. The market is then expected to grow at a CAGR of 8.6% from 2028 and reach $46.2 billion in 2033.

Growth in the historic period resulted from rise in healthcare expenditure, increase in demand for personalized medicine, high prevalence of infectious diseases and government initiatives for research and development in healthcare. Factors that negatively affected growth in the historic period were low healthcare access and high costs.

Going forward, strong economic growth, increase in the aging population, increasing number of clinical trials and increasing chronic diseases will drive the growth. Factor that could hinder the growth of the immunodiagnostics market in the future include regulatory hurdles.

The immunodiagnostics market is segmented by product into reagents and consumables, instruments and software and services. The reagents and consumables market was the largest segment of the immunodiagnostics market segmented by product, accounting for 52% or $11.1 billion of the total in 2023. Going forward, the software and services segment is expected to be the fastest growing segment in the immunodiagnostics market segmented by product, at a CAGR of 9% during 2023-2028.

The immunodiagnostics market is segmented by application into infectious diseases, oncology and endocrinology, bone and mineral diseases, autoimmunity disorders, cardiac biomarkers, hepatitis and retrovirus Testing and other applications. The oncology and endocrinology market was the largest segment of the immunodiagnostics market segmented by application, accounting for 25.6% or $5.5 billion of the total in 2023. Going forward, the cardiac biomarkers segment is expected to be the fastest growing segment in the immunodiagnostics market segmented by application, at a CAGR of 9.2% during 2023-2028.

The immunodiagnostics market is segmented by end-user into hospitals, clinics, diagnostic laboratories, academic and research institutes and other end-users. The hospitals market was the largest segment of the immunodiagnostics market segmented by end-user, accounting for 34.8% or $7.4 billion of the total in 2023. Going forward, the clinics segment is expected to be the fastest growing segment in the immunodiagnostics market segmented by end-user, at a CAGR of 8.7% during 2023-2028.

The immunodiagnostics market is segmented by technology into enzyme-linked immunosorbent assay, chemiluminescence immunoassay, fluorescent immunoassay, radioimmunoassay, rapid test and other technologies. The enzyme-linked immunosorbent assay market was the largest segment of the immunodiagnostics market segmented by technology, accounting for 38.5% or $8.2 billion of the total in 2023. Going forward, the rapid test segment is expected to be the fastest growing segment in the immunodiagnostics market segmented by technology, at a CAGR of 8.2% during 2023-2028.

North America was the largest region in the immunodiagnostics market, accounting for 32.6% or $6.9 billion of the total in 2023. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the immunodiagnostics market will be Asia Pacific and Western Europe where growth will be at CAGRs of 8.6% and 7.8% respectively. These will be followed by North America and Eastern Europe where the markets are expected to grow at CAGRs of 7.4% and 6.5% respectively.

The global immunodiagnostics market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 23.25% of the total market in 2022. Abbott Laboratories was the largest competitor with 5.69% share of the market, followed by F. Hoffmann-La Roche Ltd with 5.06%, Thermo Fisher Scientific Inc. with 4.34%, Danaher Corporation with 2.74%, DiaSorin S.p.A. with 2.41%, Bio-Rad Laboratories Inc. with 1.05%, Sysmex Corporation with 0.90%, QIAGEN with 0.46%, QuidelOrtho Corporation with 0.33%, and Immunodiagnostic Systems with 0.27%.

Market-trend-based strategies for the immunodiagnostics market include introduction of point-of-care immunodiagnostics to provide rapid results, increasing immunoassay sensitivity using DNA amplification technology and strategic partnership among market players.

The top opportunities in the immunodiagnostics market segmented by product will arise in the reagents and consumables segment, which will gain $4.9 billion of global annual sales by 2028. The top opportunities in the immunodiagnostics market segmented by application will arise in the oncology and endocrinology segment, which will gain $2.7 billion of global annual sales by 2028. The top opportunities in the immunodiagnostics market segmented by end-user will arise in the hospitals segment, which will gain $3 billion of global annual sales by 2028. The top opportunities in the immunodiagnostics market segmented by technology will arise in the enzyme-linked immunosorbent assay segment, which will gain $3.9 billion of global annual sales by 2028. The immunodiagnostics market size will gain the most in the USA at $2.7 billion.

Player-adopted strategies in the immunodiagnostics market include focus on enhancing operational and manufacturing capabilities through new product launches and strategic partnerships.

To take advantage of the opportunities, the analyst recommends the immunodiagnostics companies to focus on point-of-care immunodiagnostics for rapid solutions, focus on enhancing immunoassay sensitivity with DNA amplification technology, focus on reagents and consumables, and software and services segments for growth, focus on rapid test and enzyme-linked immunosorbent assay segments for growth, expand in emerging markets, continue to focus on developed markets, focus on strategic partnerships for enhanced immunodiagnostics, provide competitively priced offerings, continue to use B2B promotions, focus on cardiac biomarkers and oncology & endocrinology segments and focus on clinics and hospitals.

Table of Contents

1 Executive Summary
1.1 Immunodiagnostics - Market Attractiveness and Macro Economic Landscape
2 Table of Contents3 List of Tables4 List of Figures5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 Immunodiagnostics Market Definition and Segmentations
6.4 Market Segmentation by Product
6.4.1 Reagents and Consumables
6.4.2 Instruments
6.4.3 Software and Services
6.5 Market Segmentation by Technology
6.5.1 Enzyme-Linked Immunosorbent Assay
6.5.2 Chemiluminescence Immunoassay
6.5.3 Fluorescent Immunoassay
6.5.4 Radioimmunoassay
6.5.5 Rapid Test
6.5.6 Other Technologies
6.6 Market Segmentation by Application
6.6.1 Infectious Diseases
6.6.2 Oncology and Endocrinology
6.6.3 Bone and Mineral Diseases
6.6.4 Autoimmune Disorders
6.6.5 Cardiac Biomarkers
6.6.6 Hepatitis and Retrovirus Testing
6.6.7 Other Applications
6.7 Market Segmentation by End-User
6.7.1 Hospitals
6.7.2 Clinics
6.7.3 Diagnostic Laboratories
6.7.4 Academic and Research Institutes
6.7.5 Other End Users
7 Major Market Trends
7.1 Introduction of Point-Of-Care Immunodiagnostics to Provide Rapid Results
7.2 Increasing Immunoassay Sensitivity Using DNA Amplification Technology
7.3 Strategic Partnership Among Market Players
8 Immunodiagnostics Market - Macro Economic Scenario
8.1 COVID-19 Impact on the Immunodiagnostics Market
8.2 Impact of the War in Ukraine on the Immunodiagnostics Market
8.3 Impact of High Inflation on the Immunodiagnostics Market
9 Global Market Size and Growth
9.1 Market Size
9.2 Historic Market Growth, 2018-2023, Value ($ Million)
9.2.1 Market Drivers 2018-2023
9.2.2 Market Restraints 2018-2023
9.3 Forecast Market Growth, 2023-2028, 2033F Value ($ Million)
9.3.1 Market Drivers 2023-2028
9.3.2 Market Restraints 2023-2028
10 Global Immunodiagnostics Market Segmentation
10.1 Global Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
10.2 Global Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
10.3 Global Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
10.4 Global Immunodiagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
11 Immunodiagnostics Market, Regional and Country Analysis
11.1 Global Immunodiagnostics Market, by Region, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
11.2 Global Immunodiagnostics Market, by Country, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12 Asia-Pacific Market
12.1 Summary
12.2 Market Overview
12.2.1 Region Information
12.2.2 Market Information
12.2.3 Background Information
12.2.4 Government Initiatives
12.2.5 Regulations
12.2.6 Regulatory Bodies
12.2.7 Major Associations
12.2.8 Taxes Levied
12.2.9 Corporate Tax Structure
12.2.10 Investments
12.2.11 Major Companies
12.3 Asia-Pacific Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.4 Asia-Pacific Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.6 Asia-Pacific Immunodiagnostics Market: Country Analysis
12.7 China Market
12.8 Summary
12.9 Market Overview
12.9.1 Country Information
12.9.2 Market Information
12.9.3 Background Information
12.9.4 Government Initiatives
12.9.5 Taxes Levied
12.9.6 Regulations
12.9.7 Regulatory Bodies
12.9.8 Major Associations
12.9.9 Corporate Tax Structure
12.9.10 Investments
12.9.11 Major Companies
12.10 China Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.11 China Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.12 China Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.13 India Market
12.14 India Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.15 India Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.16 India Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.17 Japan Market
12.18 Japan Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.19 Japan Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.20 Japan Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.21 Australia Market
12.22 Australia Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.23 Australia Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.24 Australia Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.25 Indonesia Market
12.26 Indonesia Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.27 Indonesia Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.28 Indonesia Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.29 South Korea Market
12.30 South Korea Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.31 South Korea Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.32 South Korea Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13 Western Europe Market
13.1 Summary
13.2 Market Overview
13.2.1 Region Information
13.2.2 Market Information
13.2.3 Background Information
13.2.4 Government Initiatives
13.2.5 Regulations
13.2.6 Regulatory Bodies
13.2.7 Major Associations
13.2.8 Taxes Levied
13.2.9 Corporate tax structure
13.2.10 Investments
13.2.11 Major Companies
13.3 Western Europe Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.5 Western Europe Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.6 Western Europe Immunodiagnostics Market: Country Analysis
13.7 UK Market
13.8 UK Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.9 UK Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.10 UK Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.11 Germany Market
13.12 Germany Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.13 Germany Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.14 Germany Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.15 France Market
13.16 France Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.17 France Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.18 France Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.19 Italy Market
13.20 Italy Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.21 Italy Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.22 Italy Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.23 Spain Market
13.24 Spain Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.25 Spain Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.26 Spain Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
14 Eastern Europe Market
14.1 Summary
14.2 Market Overview
14.2.1 Region Information
14.2.2 Market Information
14.2.3 Background Information
14.2.4 Government Initiatives
14.2.5 Regulations
14.2.6 Regulatory Bodies
14.2.7 Major Associations
14.2.8 Taxes Levied
14.2.9 Corporate Tax Structure
14.2.10 Major Companies
14.3 Eastern Europe Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
14.6 Eastern Europe Immunodiagnostics Market: Country Analysis
14.7 Russia Market
14.8 Russia Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
14.9 Russia Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
14.10 Russia Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15 North America Market
15.1 Summary
15.2 Market Overview
15.2.1 Region Information
15.2.2 Market Information
15.2.3 Background Information
15.2.4 Government Initiatives
15.2.5 Regulations
15.2.6 Regulatory Bodies
15.2.7 Major Associations
15.2.8 Taxes Levied
15.2.9 Corporate Tax Structure
15.2.10 Investments
15.2.11 Major Companies
15.3 North America Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.4 North America Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.5 North America Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.6 North America Immunodiagnostics Market: Country Analysis
15.7 USA Market
15.8 Summary
15.9 Market Overview
15.9.1 Country Information
15.9.2 Market Information
15.9.3 Background Information
15.9.4 Government Initiatives
15.9.5 Regulations
15.9.6 Regulatory Bodies
15.9.7 Major Associations
15.9.8 Taxes Levied
15.9.9 Corporate Tax Structure
15.9.10 Investments
15.9.11 Major Companies
15.10 USA Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.11 USA Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.12 USA Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.13 Canada Market
15.14 Canada Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.15 Canada Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.16 Canada Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
16 South America Market
16.1 Summary
16.2 Market Overview
16.2.1 Region Information
16.2.2 Market Information
16.2.3 Background Information
16.2.4 Government Initiatives
16.2.5 Regulations
16.2.6 Regulatory Bodies
16.2.7 Major Associations
16.2.8 Taxes Levied
16.2.9 Corporate Tax Structure
16.2.10 Investment
16.2.11 Major Companies
16.3 South America Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
16.4 South America Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
16.5 South America Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
16.6 South America Immunodiagnostics Market: Country Analysis
16.7 Brazil Market
16.8 Brazil Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
16.10 Brazil Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
17 Middle East Market
17.1 Summary
17.2 Market Overview
17.2.1 Region Information
17.2.2 Market Information
17.2.3 Background Information
17.2.4 Government Initiatives
17.2.5 Regulations
17.2.6 Regulatory Bodies
17.2.7 Major Associations
17.2.8 Taxes Levied
17.2.9 Corporate Tax Structure
17.2.10 Investments
17.2.11 Major Companies
17.3 Middle East Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
17.5 Middle East Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
18 Africa Market
18.1 Summary
18.2 Market Overview
18.2.1 Region Information
18.2.2 Market Information
18.2.3 Background Information
18.2.4 Government Initiatives
18.2.5 Regulations
18.2.6 Regulatory Bodies
18.2.7 Major Associations
18.2.8 Taxes Levied
18.2.9 Corporate Tax Structure
18.2.10 Investments
18.2.11 Major Companies
18.3 Africa Immunodiagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
18.4 Africa Immunodiagnostics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
18.5 Africa Immunodiagnostics Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
19 Competitive Landscape and Company Profiles
19.1 Company Profiles
19.2 Abbott Laboratories
19.2.1 Company Overview
19.2.2 Products and Services
19.2.3 Business Strategy
19.2.4 Financial Overview
19.3 F. Hoffman-La Roche Ltd
19.3.1 Company Overview
19.3.2 Products and Services
19.3.3 Business Strategy
19.3.4 Financial Overview
19.4 Thermo Fisher Scientific Inc.
19.4.1 Company Overview
19.4.2 Products and Services
19.4.3 Business Strategy
19.4.4 Financial Overview
19.5 Danaher Corporation
19.5.1 Company Overview
19.5.2 Products and Services
19.5.3 Business Strategy
19.5.4 Financial Overview
19.6 DiaSorin S.p.A.
19.6.1 Company Overview
19.6.2 Products and Services
19.6.3 Business Strategy
19.6.4 Financial Overview
20 Competitive Benchmarking21 Competitive Dashboard
22 Key Mergers and Acquisitions
22.1 Novacyt Acquired Yourgene Health
22.2 Freenome Acquired Oncimmune Ltd.
22.3 DiaSorin S.p.A Acquired Luminex Corporation
22.4 Avacta Group plc Acquired Launch Diagnostics Holdings Limited
22.5 Heska Acquired LightDeck Diagnostics
23 Opportunities and Strategies
23.1 Global Immunodiagnostics Market in 2028 - Countries Offering Most New Opportunities
23.2 Global Immunodiagnostics Market in 2028 - Segments Offering Most New Opportunities
23.3 Global Immunodiagnostics Market in 2028 - Growth Strategies
23.3.1 Market Trend Based Strategies
23.3.2 Competitor Strategies
24 Immunodiagnostics Market, Conclusions and Recommendations
24.1 Conclusions
24.2 Recommendations
24.2.1 Product
24.2.2 Place
24.2.3 Price
24.2.4 Promotion
24.2.5 People
25 Appendix
25.1 Geographies Covered
25.2 Market Data Sources
25.3 Research Methodology
25.4 Currencies
25.5 About the Analyst
25.6 Copyright and Disclaimer

Executive Summary

Immunodiagnostics Global Market Opportunities and Strategies to 2033 provides the strategists; marketers and senior management with the critical information they need to assess the global immunodiagnostics market as it emerges from the COVID-19 shut down.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description

Where is the largest and fastest-growing market for immunodiagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The immunodiagnostics market global report answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider immunodiagnostics market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by technology, by application and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the immunodiagnostics market.
  • Global Market Size and Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional and Country Analysis - Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by technology, by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard - Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities and Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions and Recommendations- This section includes recommendations for immunodiagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups next five years.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) by Product: Reagents and Consumables; Instruments; Software and Services
2) by Technology: Enzyme-Linked Immunosorbent Assay; Chemiluminescence Immunoassay; Fluorescent Immunoassay; Radioimmunoassay; Rapid Test; Other Technologies.
3) by Application: Infectious Diseases; Oncology and Endocrinology; Bone and Mineral Diseases; Autoimmunity Disorders; Cardiac Biomarkers; Hepatitis and Retrovirus Testing; Other Applications.
4) by End-User: Hospitals; Clinics; Diagnostic Laboratories; Academic and Research Institutes; Other End-Users.

Key Companies Mentioned: Abbott Laboratories;F. Hoffmann-La Roche Ltd;Thermo Fisher Scientific Inc.; Danaher Corporation; DiaSorin S.p.A.

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; immunodiagnostics indicators comparison.

Data Segmentation: Country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing:Data and analysis throughout the report is sourced using end notes.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Bio-Rad Laboratories Inc.
  • Sysmex Corporation
  • QIAGEN
  • QuidelOrtho Corporation
  • Immunodiagnostic Systems
  • Mindray Medical
  • YHLO-Shenzhen YHLO Biotech Co. Ltd
  • Snibe Diagnostic
  • Autobio Diagnostics Co. Ltd
  • Eurofins Amar Immunodiagnostics Pvt. Ltd.
  • Promea Therapeutics
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • Siemens Healthineers
  • bioMérieux
  • DiaSorin
  • Werfen
  • Biosynex SA
  • Euroimmun
  • BioVendor Group
  • Synektik
  • BioMaxima S.A.
  • Northern Nanopore Instruments (NNi)
  • ImmunoDiagnostics Limited
  • Ortho Clinical Diagnostics
  • GE HealthCare Technologies Inc.
  • American Laboratory Products Company Ltd.
  • PerkinElmer Inc.
  • Roche Diagnostics
  • Brazlex Medical Genetics
  • Wiener Laboratorios SAIC
  • Wama Diagnóstica
  • F Hoffmann-La Roche AG
  • Rustom Medical Est
  • Babirus Medikal Malzemeler Limited Şirketi
  • Bionik Iran
  • Sysmex South Africa (Pty) Ltd.
  • ISN Products Nig Ltd
  • Union Diagnostic and Clinical Services PLC
  • MeCure Healthcare Limited

Methodology

Loading
LOADING...

Table Information